Products Categories
CAS No.: | 21738-42-1 |
---|---|
Name: | OXAMNIQUINE(200MG)DISCONTINUED |
Molecular Structure: | |
Formula: | C14H21 N3 O3 |
Molecular Weight: | 279.339 |
Synonyms: | 6-Quinolinemethanol,1,2,3,4-tetrahydro-2-[(isopropylamino)methyl]-7-nitro- (8CI); (?à)-Oxamniquine;1,2,3,4-Tetrahydro-6-(hydroxymethyl)-2-[(isopropylamino)methyl]-7-nitroquinoline;6-Hydroxymethyl-2-isopropylaminomethyl-7-nitro-1,2,3,4-tetrahydroquinoline;Mansil; NSC 352888; Oxamniquine; UK 4261; UK 4271; Vansil |
Density: | 1.174g/cm3 |
Melting Point: | 147-149° |
Boiling Point: | 443.6°Cat760mmHg |
Flash Point: | 222.1°C |
Safety: | Poison by ingestion, intraperitoneal and intramuscular routes. Human mutation data reported. An antischistosomal agent. When heated to decomposition it emits toxic fumes of NOx. |
PSA: | 90.11000 |
LogP: | 2.86390 |
What can I do for you?
Get Best Price
Empirical Formula: C14H21N3O3
Molecular Weight: 279.3348 g/mol
EINECS: 244-556-4
Index of Refraction: 1.56
Density: 1.174 g/cm3
Flash Point: 222.1 °C
Enthalpy of Vaporization: 73.91 kJ/mol
Boiling Point: 443.6 °C at 760 mmHg
Vapour Pressure: 1.19E-08 mmHg at 25 °C
Structure of Oxamniquine (CAS NO.21738-42-1):
IUPAC Name of Oxamniquine (CAS NO.21738-42-1): [7-Nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl]methanol
Oxamniquine (CAS NO.21738-42-1) is used for treatment of schistosomiasis and is equally effective as praziquantel for treating S. mansoni infections.
1. | mmo-sat 364 nmol/plate | JPETAB Journal of Pharmacology and Experimental Therapeutics. 200 (1977),1. | ||
2. | msc-ham:lng 1 µmol/L | MUREAV Mutation Research. 157 (1985),1. | ||
3. | orl-rat LD50:30 mg/kg | DDREDK Drug Development Research. 4 (1984),229. | ||
4. | ipr-rat LD50:20 mg/kg | DDREDK Drug Development Research. 4 (1984),229. | ||
5. | ims-rat LD50:60 mg/kg | DDREDK Drug Development Research. 4 (1984),229. | ||
6. | orl-mus LD50:1300 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 31 (1981),555. | ||
7. | ipr-mus LD50:650 mg/kg | DDREDK Drug Development Research. 4 (1984),229. | ||
8. | orl-rbt LD50:500 mg/kg | DDREDK Drug Development Research. 4 (1984),229. | ||
9. | orl-ham LD50:950 mg/kg | DDREDK Drug Development Research. 4 (1984),229. |
EPA Genetic Toxicology Program.
Poison by ingestion, intraperitoneal and intramuscular routes. Human mutation data reported. An antischistosomal agent. When heated to decomposition it emits toxic fumes of NOx.
Oxamniquine ,its cas register number is 21738-42-1. It also can be called 6-Quinolinemethanol, 1,2,3,4-tetrahydro-2-((isopropylamino)methyl)-7-nitro- ; 1,2,3,4-Tetrahydro-2-[(isopropylamino)methyl]-7-nitro-6-quinolinemethanol ; and {2-[(Isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydro-6-quinolinyl}methanol . It causes worms to shift from the mesenteric veins to the liver where the male worms are retained and is a potent single-dose agent for treatment of Schistosoma mansoni infection in man. It is generally well tolerated following oral doses. Oxamniquine (CAS NO.21738-42-1) is extensively metabolised to inactive metabolites which are excreted in the urine, and is a semisynthetic tetrahydroquinoline and possibly acts by DNA binding resulting in contraction and paralysis of the worms and eventual detachment from terminal venules in the mesentry and death.